Rasha Mohammed Saleem

Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy

Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare et al. · ACS Omega · 2024 · 41 citations · Full text

Medicine, Immunology, Oncology +17

Rhamnetin, a nutraceutical flavonoid arrests cell cycle progression of human ovarian cancer (SKOV3) cells by inhibiting the histone deacetylase 2 protein

Kaushik Kumar Bharadwaj, Bijuli Rabha, Iqrar Ahmad et al. · Journal of Biomolecular Structure and Dynamics · 2023 · 25 citations

Medicine, Molecular Biology, Oncology +13

Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach

Partha Biswas, Shabana Bibi, Qudsia Yousafi et al. · Molecules · 2023 · 22 citations · Full text

Medicine, Oncology, Pharmacology +12

Design, synthesis, anti-inflammatory evaluation, and molecular modelling of new coumarin-based analogs combined curcumin and other heterocycles as potential TNF-α production inhibitors <i>via</i> upregulating Nrf2/HO-1, downregulating AKT/mTOR signalling pathways and downregulating NF-κB in LPS induced macrophages

Lina M. A. Abdel Ghany, Botros Y. Beshay, Amal M. Youssef Moustafa et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

In silico evaluation of anti-colorectal cancer inhibitors by Resveratrol derivatives targeting Armadillo repeats domain of APC: molecular docking and molecular dynamics simulation

Shopnil Akash, Md. Rezaul Islam, A. A. Bhuiyan et al. · Frontiers in Oncology · 2024 · 19 citations · Full text

Pharmacy, Oncology, Pharmacology +17